Quick Summary

Manjistha (Rubia cordifolia) is a medicinal plant traditionally used for a variety of health conditions including maternal health support, psoriasis, and liver disorders. The plant contains bioactive compounds such as anthraquinones and triterpenes, which have demonstrated potential pharmacological activities including anti-inflammatory, antioxidant, anticancer, and neuroprotective effects in preclinical studies. However, scientific validation in humans remains limited, and further rigorous clinical research is needed to confirm these benefits.

What is it?

Manjistha, scientifically known as Rubia cordifolia, is a climbing perennial plant commonly used in traditional medicine systems such as Ayurveda and Siddha. It grows in various parts of Asia and has been utilized for centuries as a herbal remedy. The root and other parts of the plant are the main sources of medicinal compounds.

Traditional Uses

  • Support in maternal health and pregnancy-related conditions in local communities.
  • Treatment of chronic plaque psoriasis and other skin diseases.
  • Management of liver disorders and as a general detoxifying agent.
  • Wound healing and skin health improvement.

Active Compounds

Manjistha contains several bioactive phytochemicals, including:

  • Anthraquinones (e.g., purpurin)
  • Triterpenes
  • Other phytochemicals with antioxidant and anti-inflammatory properties

Potential Benefits with Evidence Levels

  • Traditional use for maternal health: Insufficient clinical evidence. Used traditionally by local communities; scientific validation and safety data are limited. (PMID: 41783344)
  • Chronic plaque psoriasis: Preliminary clinical evidence from a single-patient case report shows possible improvement when used as part of Siddha therapy; no controlled trials available. (PMID: 40786349)
  • Anti-prostate cancer (in vitro): Preclinical evidence demonstrates cytotoxic activity of anthraquinones against prostate cancer cell lines. (PMID: 41709315)
  • Hepatoprotective effects: Traditional use and preclinical evidence suggest protective effects on the liver; however, direct clinical evidence for Manjistha is not established. (PMID: 41971583)
  • Neuroprotective effects of purpurin: Preclinical studies indicate antioxidant and neuroprotective activities relevant to neurodegenerative disorders. (PMID: 41045341)
  • Anti-inflammatory and antioxidant activities: Supported by preclinical and ethnopharmacological evidence; lacks human clinical validation.
  • Wound healing and skin diseases: Traditional and experimental data from animal and in vitro studies suggest benefits; robust human trials are absent.

Side Effects

No specific adverse effects have been directly attributed to Manjistha in clinical sources. However, the data are limited due to a lack of extensive clinical trials. Thus, side effects remain largely unknown.

Drug Interactions

No documented drug interactions have been reported. Due to the lack of clinical interaction studies, caution is advised when Manjistha is used concurrently with conventional medications.

Who Should Avoid It

There is insufficient data to identify specific contraindications. Although Manjistha is traditionally used in maternal health, scientific safety data during pregnancy and breastfeeding are lacking. Therefore, caution is recommended for pregnant and breastfeeding individuals until further safety information is available.

Evidence Limitations

  • Most evidence is based on preclinical studies, ethnopharmacology, or single-case reports.
  • Lack of large, high-quality randomized controlled trials evaluating efficacy and safety.
  • Variation in herbal preparations, dosage, and combination therapies complicates interpretation of results.
  • Limited data on pharmacokinetics, contraindications, and potential drug interactions.
  • Minimal human pharmacovigilance and toxicology data available.

References

Last Reviewed

June 2024


Information Disclaimer: This page is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbal supplements, especially if you are pregnant, breastfeeding, have existing health conditions, or take other medications.